Monopar’s uPA Antibody Fragment Radiotracer Shows Potential for PET Imaging of Breast Cancer in Preclinical Study

Go back to Monopar’s uPA Antibody Fragment Radiotracer Shows Potential for PET Imaging of Breast Cancer in Preclinical Study
(NASDAQ: MNPR) Delayed: 5.49 +0.38 (7.44%)
Previous Close $5.11    52 Week High
Open $5.15    52 Week Low
Day High $5.49    P/E N/A 
Day Low $5.15    EPS
Volume 24,870